Effect of UDCA on fecal bile acids composition of IBD patients: pilot study. [Invloed van UDCA op fecale galzouten samenstelling van IBD patienten: piloot studie.]

Trial Profile

Effect of UDCA on fecal bile acids composition of IBD patients: pilot study. [Invloed van UDCA op fecale galzouten samenstelling van IBD patienten: piloot studie.]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Jan 2015

At a glance

  • Drugs Ursodeoxycholic acid (Primary)
  • Indications Crohn's disease; Ulcerative colitis
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 27 Dec 2014 Planned number of patients changed from 60 to 80 as reported by European Clinical Trials Database record.
    • 13 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top